EYESW (Second Sight Medical Products) DeferredTaxAndRevenue: $0.34 Mil (As of Jun. 2022)


What is Second Sight Medical Products DeferredTaxAndRevenue?

Second Sight Medical Products EYESW DeferredTaxAndRevenue is $0.34 Mil as of Jun. 2022. The stock has 1 warning sign investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Second Sight Medical Products's current deferred tax and revenue for the quarter that ended in Jun. 2022 was $0.34 Mil.

Second Sight Medical Products DeferredTaxAndRevenue Related Terms

Second Sight Medical Products DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Second Sight Medical Products's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Second Sight Medical Products DeferredTaxAndRevenue Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.17 0.34 0.00 0.00

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.34 0.00 0.00 0.34
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.34 Mil mean?
Second Sight Medical Products (EYESW) has a DeferredTaxAndRevenue of $0.34 Mil as of Jun. 2022. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Second Sight Medical Products.
Is Second Sight Medical Products' DeferredTaxAndRevenue too high?
Second Sight Medical Products' current DeferredTaxAndRevenue is $0.34 Mil.
How does Second Sight Medical Products' DeferredTaxAndRevenue compare to SONX and LUCD?
Second Sight Medical Products' DeferredTaxAndRevenue of $0.34 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Second Sight Medical Products. Second Sight Medical Products's current DeferredTaxAndRevenue is $0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Second Sight Medical Products stock overvalued right now?
Second Sight Medical Products (EYESW) has a current DeferredTaxAndRevenue of $0.34 Mil. The current DeferredTaxAndRevenue is $0.34 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Second Sight Medical Products (EYESW), the current DeferredTaxAndRevenue is $0.34 Mil as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Second Sight Medical Products Business Description

Address 13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.